First-in-Class Drug Could Benefit CKD Patients

Share this content:

A new first-in-class agent shows promise for improving outcomes in chronic kidney disease patients undergoing surgical placement of an arteriovenous fistula in preparation for hemodialysis. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters